Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Atrial Fibrillation at the European Society of Cardiology (ESC) Congress 2009

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
2,627
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Sep 15, 2009

RELY, a randomized trial of dabigatran, a oral direct thrombin inhibitor, compared to warfarin in 18,113 patients with atrial fibrillation at high risk of stroke; Atrial fibrillation ablation versus treatment; ACTIVE-I, a randomized evaluation of irbesartan versus placebo in patients with atrial fibrillation

Category:

Science & Technology

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more